Bill Sibold
-
Madrigal’s Rezdiffra Nears Blockbuster Status With $958M in First Full Year on Market
In its first full year on the market, West Conshohocken-based Madrigal Pharmaceuticals’ flagship drug Rezdiffra nearly got to blockbuster status,…
-
Madrigal Pharmaceuticals Expands As Breakthrough Drug Fuels Growth
West Conshohocken’s Madrigal Pharmaceuticals is relocating its headquarters to accommodate rapid expansion, reports John George for The Philadelphia Business Journal.…
-
Conshohocken’s Madrigal Pharmaceuticals Reports Sales Through the Roof
Conshohocken’s Madrigal Pharmaceuticals, saw third-quarter sales soar for its NASH treatment, Rezdiffra, writes John George for the Philadelphia Business Journal.…
-
Madrigal Pharmaceuticals in Conshohocken Reports $14.6 Million in Sales from Groundbreaking NASH Drug Rezdiffra
Conshohocken-based Madrigal Pharmaceuticals generated $14.6 million in sales from Rezdiffra, its first and flagship product, during the second quarter of…
-
Conshohocken-based Madrigal Pharmaceuticals Launches Groundbreaking NASH Drug, Rezdiffra
In the less than two months since becoming the first drug developer to receive Food and Drug Administration clearance for…
-
Madrigal Pharmaceuticals First to Receive FDA Clearance for a NASH Treatment
Madrigal Pharmaceuticals has been given Food and Drug Administration market clearance for its experimental treatment for NASH, a fatty liver…
-
All Eyes Are on Madrigal Pharmaceuticals as FDA’s Decision Draws Closer
Later this week, the U.S. Food and Drug Administration is expected to make a decision on Madrigal Pharmaceuticals’ experimental NASH…
-
Conshohocken-Based Madrigal’s Liver Disease Treatment Gets Priority Review by FDA
A Conshohocken-based pharmaceutical company’s treatment for nonalcoholic steatoheptatitis (NASH) a severe form of liver disease, is getting priority review by…
-
Former Sanofi Executive Named CEO of Conshohocken-based Madrigal Pharmaceuticals
Conshohocken biopharmaceutical company Madrigal Pharmaceuticals has named Bill Sibold as the new CEO taking over from Dr. Paul Friedman. He…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
